Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01803737 · ClinicalTrials.gov registry record · NA

Feasibility of a Campaign Intervention Compared to a Standard Behavioral Weight Loss Intervention in Overweight and Obese Adults

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
26
Enrollment target

NCT01803737: Completed NA study, sponsored by University of Pittsburgh.

NCT01803737 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01803737, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target

Study Summary

The purpose of this study is to examine the feasibility of a campaign intervention for weight management compared to a standard behavioral weight loss intervention in overweight and obese adults.

Primary Outcome

Body weight will be measured on a digital scale to assess change in body weight over the 12-week intervention period.

Interventions

  • BEHAVIORAL Standard Behavioral Weight Loss Intervention (SBWL)
  • BEHAVIORAL Campaign Intervention (CI)

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2013-01
Est. Completion 2013-07
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT01803737 record still lists

NCT01803737 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard Behavioral Weight Loss Intervention (SBWL) is the first listed.

NCT01803737 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01803737 about?

NCT01803737 is a clinical study titled "Feasibility of a Campaign Intervention Compared to a Standard Behavioral Weight Loss Intervention in Overweight and Obese Adults". The purpose of this study is to examine the feasibility of a campaign intervention for weight management compared to a standard behavioral weight loss intervention in overweight and obese adults.

What is the current status of trial NCT01803737?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2013-01. Estimated completion is 2013-07.

What interventions are being tested in trial NCT01803737?

The interventions under investigation include: Standard Behavioral Weight Loss Intervention (SBWL) (BEHAVIORAL), Campaign Intervention (CI) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01803737?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01803737's enrollment target sits among peer trials

26 1710th of 2000 higher than 289 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01803737, the US trial registry maintained by the National Library of Medicine. NCT01803737 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.